Toleranzia AB Sustainability Reports
Toleranzia AB specializes in developing innovative therapies for autoimmune diseases using its proprietary protein-based technology.
Sector: Health Care
Country: Sweden
Exchange: Nasdaq Stockholm
ISIN: SE0007438577
1 reports from 2024 to 2024
Company Profile
Toleranzia AB
Toleranzia AB specializes in developing innovative therapies for autoimmune diseases using its proprietary protein-based technology.
Reports